Literature DB >> 25624331

Major pathways of polymyxin-induced apoptosis in rat kidney proximal tubular cells.

Mohammad A K Azad1, Jesmin Akter1, Kelly L Rogers2, Roger L Nation1, Tony Velkov3, Jian Li3.   

Abstract

Identifying the pathways involved in the apoptotic cell death that is associated with polymyxin-induced nephrotoxicity is crucial for the development of strategies to ameliorate this dose-limiting side effect and for the development of novel safer polymyxins. The primary aim of this study was to identify the major pathways which lead to polymyxin-induced apoptosis in cultured rat kidney proximal tubular cells (NRK-52E). Caspase-3, -8, and -9 were activated by polymyxin B treatment in a concentration-dependent manner. Concentration- and time-dependent expression of FasL and deformation of mitochondrial morphology were revealed following polymyxin B treatment. The proportion of cells with filamentous mitochondria (regular morphology) following an 8-h treatment with 1.0 mM polymyxin B was 56.2% ± 9.7% (n = 3). This was decreased to 30.7% ± 7.5% when the polymyxin B concentration was increased to 2.0 mM. The mitochondrial membrane potential (Δψm) decreased to 14.1% ± 2.9% in the cells treated with 1.0 mM polymyxin B for 24 h (n = 3) compared to that in the untreated control group. Concomitantly, concentration- and time-dependent production of mitochondrial superoxide was also observed. This study is the first to have demonstrated that polymyxin-induced apoptosis is mediated through both the death receptor and mitochondrial pathways in cultured renal tubular cells. It provides key information not only for the amelioration of polymyxin-induced nephrotoxicity but also for the discovery of novel safer polymyxin-like antibiotics against Gram-negative "superbugs."
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25624331      PMCID: PMC4356794          DOI: 10.1128/AAC.04869-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  47 in total

1.  Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis.

Authors:  E Gottlieb; S M Armour; M H Harris; C B Thompson
Journal:  Cell Death Differ       Date:  2003-06       Impact factor: 15.828

Review 2.  Antibiotics in the clinical pipeline in 2013.

Authors:  Mark S Butler; Mark A Blaskovich; Matthew A Cooper
Journal:  J Antibiot (Tokyo)       Date:  2013-09-04       Impact factor: 2.649

Review 3.  Death and anti-death: tumour resistance to apoptosis.

Authors:  Frederik H Igney; Peter H Krammer
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

4.  Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics.

Authors:  Jumana M Yousef; Gong Chen; Prue A Hill; Roger L Nation; Jian Li
Journal:  J Antimicrob Chemother       Date:  2011-11-28       Impact factor: 5.790

5.  Analysis of mitochondrial dynamics and functions using imaging approaches.

Authors:  Kasturi Mitra; Jennifer Lippincott-Schwartz
Journal:  Curr Protoc Cell Biol       Date:  2010-03

6.  Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways.

Authors:  Chongshan Dai; Jichang Li; Shusheng Tang; Jian Li; Xilong Xiao
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

7.  Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.

Authors:  S M Garonzik; J Li; V Thamlikitkul; D L Paterson; S Shoham; J Jacob; F P Silveira; A Forrest; R L Nation
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

Review 8.  The role of mitochondria in apoptosis*.

Authors:  Chunxin Wang; Richard J Youle
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

9.  Differential proteomic analysis of human erythroblasts undergoing apoptosis induced by epo-withdrawal.

Authors:  Stéphanie Pellegrin; Kate J Heesom; Timothy J Satchwell; Bethan R Hawley; Geoff Daniels; Emile van den Akker; Ashley M Toye
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

10.  Significant accumulation of polymyxin in single renal tubular cells: a medicinal chemistry and triple correlative microscopy approach.

Authors:  Mohammad A K Azad; Kade D Roberts; Heidi H Yu; Boyin Liu; Alice V Schofield; Simon A James; Daryl L Howard; Roger L Nation; Kelly Rogers; Martin D de Jonge; Philip E Thompson; Jing Fu; Tony Velkov; Jian Li
Journal:  Anal Chem       Date:  2015-01-15       Impact factor: 6.986

View more
  29 in total

1.  Cellular Uptake and Localization of Polymyxins in Renal Tubular Cells Using Rationally Designed Fluorescent Probes.

Authors:  Bo Yun; Mohammad A K Azad; Cameron J Nowell; Roger L Nation; Philip E Thompson; Kade D Roberts; Tony Velkov; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins.

Authors:  Xiaoxi Lu; Ting Chan; Chenghao Xu; Ling Zhu; Qi Tony Zhou; Kade D Roberts; Hak-Kim Chan; Jian Li; Fanfan Zhou
Journal:  J Antimicrob Chemother       Date:  2015-10-22       Impact factor: 5.790

Review 3.  Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.

Authors:  Pamela Brown; Michael J Dawson
Journal:  J Antibiot (Tokyo)       Date:  2017-01-11       Impact factor: 2.649

4.  Intracellular localization of polymyxins in human alveolar epithelial cells.

Authors:  Maizbha U Ahmed; Tony Velkov; Qi Tony Zhou; Alex J Fulcher; Judy Callaghan; Fanfan Zhou; Kim Chan; Mohammad A K Azad; Jian Li
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

5.  Synchrotron-based X-ray fluorescence microscopy reveals accumulation of polymyxins in single human alveolar epithelial cells.

Authors:  Mohamad A K Azad; Shuo Zhang; Jiayao Li; Yeonuk Kim; Heidi H Yu; Alex J Fulcher; Daryl L Howard; Martin D de Jonge; Simon A James; Kade D Roberts; Tony Velkov; Jing Fu; Qi Tony Zhou; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2021-03-01       Impact factor: 5.191

6.  A Population WB-PBPK Model of Colistin and its Prodrug CMS in Pigs: Focus on the Renal Distribution and Excretion.

Authors:  Alexis Viel; Jérôme Henri; Salim Bouchène; Julian Laroche; Jean-Guy Rolland; Jacqueline Manceau; Michel Laurentie; William Couet; Nicolas Grégoire
Journal:  Pharm Res       Date:  2018-03-12       Impact factor: 4.200

Review 7.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

8.  Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative Bacteria.

Authors:  Kade D Roberts; Mohammad A K Azad; Jiping Wang; Andrew S Horne; Philip E Thompson; Roger L Nation; Tony Velkov; Jian Li
Journal:  ACS Infect Dis       Date:  2015-09-04       Impact factor: 5.084

9.  A Novel Chemical Biology Approach for Mapping of Polymyxin Lipopeptide Antibody Binding Epitopes.

Authors:  Tony Velkov; Bo Yun; Elena K Schneider; Mohammad A K Azad; Olan Dolezal; Faye C Morris; Roger L Nation; Jiping Wang; Ke Chen; Heidi H Yu; Lv Wang; Philip E Thompson; Kade D Roberts; Jian Li
Journal:  ACS Infect Dis       Date:  2016-03-29       Impact factor: 5.084

10.  Baicalein acts as a nephroprotectant that ameliorates colistin-induced nephrotoxicity by activating the antioxidant defence mechanism of the kidneys and down-regulating the inflammatory response.

Authors:  Chongshan Dai; Shusheng Tang; Yang Wang; Tony Velkov; Xilong Xiao
Journal:  J Antimicrob Chemother       Date:  2017-09-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.